Fougera Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Fougera Pharmaceuticals Ownership

Who owns Fougera Pharmaceuticals?

Fougera Pharmaceuticals is owned by Novartis AG. It was acquired on May 2, 2012.

Was Fougera Pharmaceuticals formerly PE-backed?

Yes. Fougera Pharmaceuticals was formerly owned by 3 private investors.

Fougera Pharmaceuticals Business Overview

Where is Fougera Pharmaceuticals headquartered?

Fougera Pharmaceuticals is headquartered in Melville, New York.

How many employees does Fougera Pharmaceuticals have?

Fougera Pharmaceuticals has 700 employees.

What sector is Fougera Pharmaceuticals in?

Fougera Pharmaceuticals is a life science company.

When was Fougera Pharmaceuticals founded?

Fougera Pharmaceuticals was founded in 1849.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.

Fougera Pharmaceuticals, Inc.

60 Baylis Road,
Melville, New York 11747
United States,
(631) 454-7677
www.fougerapharmaceuticals.com

Fougera Pharmaceuticals Inc. operates two primary divisions in the US focused on specialty pharmaceuticals in dermatology: Fougera, its generic dermatology medicines business, and PharmaDerm, its branded dermatology business. Founded in 1849, the Fougera division is the leading manufacturer and distributor of a wide range of topical products. The PharmaDerm division is dedicated to developing and commercializing novel prescription products to treat diseases and conditions of the skin – the largest organ of the human body.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.